Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-05-03

Clinical Trial Update: Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal Bleeding [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating a prostate immobilization device used during radiation to reduce rectal bleeding in prostate cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED